NNNN

Handel nachbörslich: 27.85 0.69 +2.54%

Anbio Biotechnology (NNNN)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Anbio Biotechnology Stock (NNNN) Company Profile

Anbio Biotechnology

Healthcare (1108)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NNNN's Discussions on Twitter

Compare NNNN vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NNNN Anbio Biotechnology	27.16	1.09B	0	0	0	0.00
ISRG Intuitive Surgical Inc	496.12	175.84B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	180.62	48.87B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	79.39	39.53B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	259.62	38.39B	5.40B	1.49B	1.78B	10.12
MDLN Medline Inc	45.04	37.69B	27.43B	1.27B	1.01B	1.5829

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Es liegen keine Finanzdaten für Anbio Biotechnology (NNNN) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Anbio Biotechnology (NNNN)

Anbio Biotechnology Stock (NNNN) Company Profile

Compare NNNN vs ISRG, BDX, ALC, RMD, MDLN

Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten

Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Why Anbio Biotechnology Class A Shares Took Off - TipRanks

Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks

Why Anbio Biotechnology Class A Shares Are Surging - TipRanks

InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa

Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria

Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks

Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com

Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews

Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com

S&P 500 Futures Up in Premarket Trading; QXO, Mosaic Lag - Barron's

Anbio Biotechnology falls -5.8% - MSN

Anbio Biotechnology (NASDAQ:NNNN) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - simplywall.st

Anbio Biotechnology's (NASDAQ:NNNN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance

Anbio Biotechnology Posts Higher Margins and Profits Despite Revenue Dip in First Half of 2025 - The Globe and Mail

Intel, Oracle among market cap stock movers on Monday - Investing.com

Anbio Biotechnology | 6-K: Report of foreign private issuer (related to financial reporting) - 富途牛牛

Anbio Biotechnology Reports Earnings Results for the Half Year Ended June 30, 2025 - marketscreener.com

Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks

Coupang and Regencell among market cap stock movers on Friday By Investing.com - Investing.com India

Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks

Year-End Review | The 2025 US IPO Gainers List is Out! Anbio Biotechnology Soars Over 570%, 'First Stablecoin Stock' Circle Surges More Than 180% - 富途牛牛

Anbio Biotechnology rises 11.2% - MSN

Why Anbio Biotechnology Class A Shares Are Rising - TipRanks

Top US Stock Losers Today (December 10, 2025): Why Polestar, AeroVironment, Aegon and Other Names Are Sinking - ts2.tech

Biggest Stock Losers Today (December 5, 2025): Parsons, Adaptive Biotechnologies, SentinelOne, SoFi and More Slide Despite Calm Markets - TechStock²

Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews

Why UiPath Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Benzinga

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Strong Buy Ratings Signal Potential 25.69% Upside - DirectorsTalk Interviews

Anbio Biotechnology (NNNN) Stock Analysis Report | Financials & Insights - Benzinga

Anbio Biotechnology plummets 56% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria

Anbio Biotechnology trading resumes - MSN

eToro adds 39 US stocks to lineup of investment instruments - FX News Group

Working capital per share of Anbio Biotechnology Class A – DUS:N3B - TradingView

Anbio Biotechnology rises 15.4% - MSN

Anbio Biotechnology Shares Surge Amid Auditor Appointment - TipRanks

Anbio BiotechnologyClass A Ordinary Shares (Nasdaq:NNNN) Stock Quote | Star Tribune - FinancialContent

Anbio Biotechnology Appoints New Auditor - TipRanks

Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility In The Healthcare Sector - DirectorsTalk Interviews

[6-K] Anbio Biotechnology Current Report (Foreign Issuer) | NNNN SEC FilingForm 6-K - Stock Titan

Anbio Biotechnology (N3B.F) latest press releases and corporate news - Yahoo Finance UK

Anbio Biotechnology trading halted, volatility trading pause - MSN

AMD, Palantir among market cap stock movers on Thursday By Investing.com - Investing.com Australia

Medtech test developer Anbio files for $9M US IPO - MSN

Why Anbio Biotechnology Class A Stocks Are Tumbling - TipRanks

AMD, Palantir among market cap stock movers on Thursday - Investing.com

Anbio Biotechnology Shares on a Wild Ride - TipRanks

Finanzdaten der Anbio Biotechnology-Aktie (NNNN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NNNN